![]() |
市场调查报告书
商品编码
1949648
兽用化学分析仪市场 - 全球产业规模、份额、趋势、机会及预测(按类型、产品、应用、最终用途、地区和竞争格局划分),2021-2031年Veterinary Chemistry Analyzer Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Product, By Species, By Application, By End-use, By Region & Competition, 2021-2031F |
||||||
全球兽用化学分析仪市场预计将从 2025 年的 31.3 亿美元大幅成长至 2031 年的 68.1 亿美元,复合年增长率为 13.83%。
这些诊断仪器对于分析血浆、尿液和血液样本至关重要,可用于识别特定的蛋白质、电解质和代谢物,从而有助于控制和检测家畜和伴侣动物的疾病。市场扩张的主要驱动力是全球对动物预防保健日益重视以及通用感染疾病的上升趋势。此外,宠物饲养量的增加以及兽医诊所和实验室对快速准确诊断结果的需求不断增长,也进一步推动了对这些仪器的需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 31.3亿美元 |
| 市场规模:2031年 | 68.1亿美元 |
| 复合年增长率:2026-2031年 | 13.83% |
| 成长最快的细分市场 | 猪肉 |
| 最大的市场 | 北美洲 |
儘管市场呈现成长态势,但仍面临许多障碍,主要原因在于实施和维护这些先进分析系统高成本。根据美国宠物用品协会 (APPA) 预测,到 2024 年,美国兽医保健支出和产品销售额预计将达到 398 亿美元,这表明人们对维护动物健康的强烈经济投入支撑了对这类设备的需求。然而,高昂的购置门槛,尤其是在某些地区兽医专业人员短缺的情况下,阻碍了此类设备的广泛应用。因此,这些经济因素可能会限制市场渗透,尤其是在资源有限的开发中国家。
宠物保险的日益普及正成为全球兽用化学分析仪市场的重要驱动力,显着降低了宠物主人获得先进诊断服务的经济门槛。随着保险范围扩大,涵盖的诊断项目增多,宠物饲主也更愿意核准先前因费用问题而放弃的全面代谢筛检和血液生化检查。这种经济支持使兽医专业人员能够更积极地实践实证医学,并利用院内化学分析仪进行慢性病监测和麻醉前检查。北美宠物健康保险协会的数据也印证了这个趋势,数据显示,截至2025年4月,北美投保宠物的数量将增加至703万隻,比上一年增长12.2%。这与照护现场技术的日益普及密切相关。
同时,不断上涨的兽医保健成本正在推动市场发展,而这又受到全球「宠物人性化」趋势的驱动,即宠物被视为家庭成员。这种文化转变促使饲主更愿意投资于预防性护理和先进的疾病管理,从而维持了对快速、准确的化学分析的需求。根据澳洲动物药品协会(Animal Medicines Australia)预测,到2025年9月,澳洲家庭在宠物上的支出预计将达到每年213亿澳元,反映出动物健康已成为人们关注的重点。这种强劲的消费环境正在推动诊断公司的创新,凸显了伴侣动物健康产业的韧性和扩张潜力。例如,硕腾(Zoetis)在2025年2月公布的数据显示,其2024财年全年营业收入成长了11%。
全球兽用化学分析仪市场成长的主要障碍之一是购买和维护先进诊断系统的高昂成本。尤其是中小型独立兽医诊所,其利润率通常较低,难以承担高端分析仪所需的大量资本投入。除了初始购置成本外,持续的营运费用,例如专业技术支援、定期校准和专用试剂等,进一步增加了总拥有成本。因此,许多兽医选择将检测外包给外部实验室,以避免内部设备带来的财务风险,这项决定直接降低了照护现场设备的销售量。
更广泛的经济状况进一步加剧了兽医诊所面临的财务压力。 2024年10月,兽医院管理协会报告称,过去12个月兽医服务的通货膨胀率上涨了8%,远高于整体经济的通货膨胀以金额为准。营运成本的增加限制了可用于投资新技术的可用资金。由于诊所在努力平衡不断上涨的营运成本和维持价格敏感型客户的稳定收费的同时,往往会推迟购买昂贵的诊断设备,导致已开发市场和新兴市场的市场渗透率和成长停滞不前。
人工智慧 (AI) 和机器学习的整合正在改变全球兽用化学分析仪市场,实现自动化诊断解读并提高工作流程效率。兽医专业人员越来越多地利用人工智慧驱动的演算法来分析化学检测结果,这一转变最大限度地减少了人为错误,并加快了紧急情况下的临床决策。这些技术直接整合到分析仪软体中,可以检测出原本会被忽略的异常情况,实际上相当于为从业人员提供了第二意见,并有助于缓解人员短缺问题。正如 Covetrus 在 2024 年 7 月发表的题为《人工智慧革命:技术如何改变兽医学》的报导中所述,约 40% 的兽医机构已经采用了人工智慧工具,这标誌着数位化诊断正在发生显着转变。
同时,随着诊所优先考虑快速就地检验( POCT)的普及速度正在加快。这一趋势得益于紧凑型全自动桌上型系统的广泛应用,这些系统使兽医能够在一次就诊中完成全面的代谢指标检测,从而提高饲主的留存率和治疗效果。儘管整个产业面临经济压力,但全球硬体安装量的持续成长也印证了对诊所内诊断能力的需求。例如,IDEXX Laboratories 在 2024 年 10 月发布的「2024 年第三季」财报中指出,其高端仪器的全球安装量同比增长了 10%,这证实了诊所对分析基础设施的依赖性日益增强。
The Global Veterinary Chemistry Analyzer Market is projected to experience significant growth, expanding from USD 3.13 Billion in 2025 to USD 6.81 Billion by 2031 at a CAGR of 13.83%. These diagnostic instruments are essential for analyzing plasma, urine, and blood samples to identify specific proteins, electrolytes, and metabolites, thereby facilitating the management and detection of diseases in both livestock and companion animals. This market expansion is primarily underpinned by a growing global focus on preventive animal health and the increasing prevalence of zoonotic diseases. Additionally, the rise in pet ownership rates and the escalating need for rapid, precise diagnostic results in veterinary clinics and reference laboratories further strengthen the demand for these devices.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.13 Billion |
| Market Size 2031 | USD 6.81 Billion |
| CAGR 2026-2031 | 13.83% |
| Fastest Growing Segment | Porcine |
| Largest Market | North America |
Despite this growth trajectory, the market encounters substantial hurdles, primarily due to the high costs associated with acquiring and maintaining these sophisticated analytical systems. According to the American Pet Products Association, expenditure on veterinary care and product sales in the United States reached $39.8 billion in 2024, indicating a strong financial commitment to animal wellness that supports the demand for such equipment. However, the steep financial barrier of ownership, often exacerbated by a lack of skilled veterinary professionals in specific regions, poses a challenge to widespread adoption. Consequently, these economic factors may limit market penetration, particularly within developing economies where resources are constrained.
Market Driver
The increasing availability of pet insurance acts as a vital catalyst for the Global Veterinary Chemistry Analyzer Market, significantly reducing the financial obstacles to accessing advanced diagnostic care. As insurance policies expand to cover more diagnostic procedures, pet owners are increasingly willing to authorize comprehensive metabolic screenings and blood chemistry panels that were previously rejected due to cost. This financial support enables veterinary professionals to practice evidence-based medicine more assertively, utilizing in-house chemistry analyzers for chronic disease monitoring and pre-anesthetic testing. Data from the North American Pet Health Insurance Association highlights this trend, noting that by April 2025, the number of insured pets in North America had risen to 7.03 million by the end of 2024, a 12.2% increase from the prior year that correlates with higher usage of point-of-care diagnostics.
Simultaneously, the market is driven by rising expenditures on veterinary healthcare, fueled largely by the global trend of pet humanization, where animals are treated as essential family members. This cultural shift fosters a greater willingness among owners to invest in preventative healthcare and sophisticated disease management, thereby sustaining the demand for immediate and accurate chemical analysis. According to Animal Medicines Australia, national household spending on pets was projected to reach $21.3 billion annually by September 2025, reflecting a prioritization of animal wellness. This robust spending environment encourages diagnostic companies to innovate, as evidenced by Zoetis, which reported an 11% operational revenue growth for the full year 2024 in February 2025, underscoring the resilience and expansion of the companion animal health sector.
Market Challenge
The primary obstacle hindering the growth of the Global Veterinary Chemistry Analyzer Market is the substantial expense associated with purchasing and maintaining advanced diagnostic systems. Veterinary practices, especially small to medium-sized independent clinics, often operate with narrow profit margins, making the heavy capital investment required for high-end analyzers difficult to justify. Beyond the initial acquisition cost, the total cost of ownership is further inflated by recurring expenses for specialized technical support, regular calibration, and proprietary reagents. Consequently, many practitioners choose to outsource testing to external reference laboratories to avoid the financial risks of in-house equipment, a decision that directly reduces the sales volume of point-of-care devices.
This financial pressure is further intensified by the broader economic conditions affecting veterinary practice management. In October 2024, the Veterinary Hospital Managers Association reported that veterinary service inflation had risen by 8% over the previous twelve months, a rate significantly exceeding general economic inflation. This increase in operational costs limits the disposable capital available for investing in new technologies. As clinics struggle to balance rising overheads while maintaining stable fees for price-sensitive clients, the procurement of expensive diagnostic machinery is often postponed, effectively stalling market penetration and growth in both developed and emerging markets.
Market Trends
The Global Veterinary Chemistry Analyzer Market is being transformed by the integration of Artificial Intelligence and Machine Learning, which are automating diagnostic interpretation and improving workflow efficiency. Veterinary professionals are increasingly utilizing AI-driven algorithms to analyze chemistry results, a shift that minimizes manual errors and accelerates clinical decision-making during critical care situations. These technologies are being embedded directly into analyzer software to detect abnormalities that might otherwise be overlooked, effectively serving as a second opinion for practitioners and helping to mitigate staffing shortages. As noted in a July 2024 article by Covetrus titled 'The AI Revolution: How Technology is Transforming Veterinary Care,' nearly 40% of veterinary practices have adopted AI-enabled tools, indicating a significant move toward digitized diagnostics.
Concurrently, there is an accelerated adoption of Point-of-Care testing as clinics prioritize immediate turnaround times over outsourcing to reference laboratories. This trend is driven by the availability of compact, fully automated benchtop systems that allow veterinarians to perform comprehensive metabolic panels during a single office visit, thereby enhancing client compliance and treatment outcomes. The demand for these on-site diagnostic capabilities is evidenced by the continued expansion of hardware placements globally, despite industry-wide economic pressures. For instance, IDEXX Laboratories reported in its 'Third Quarter 2024 Results' in October 2024 that the company achieved a 10% year-over-year increase in its global installed base of premium instruments, underscoring the growing reliance on in-house analytical infrastructure.
Report Scope
In this report, the Global Veterinary Chemistry Analyzer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Chemistry Analyzer Market.
Global Veterinary Chemistry Analyzer Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: